Can low selenium contribute to low free T3 despite preserved free T4?

Clinical evidence of selenium-mediated thyroid regulation

• Hormone alteration pattern: In populations with overt or severe selenium deficiency, clinical data demonstrate a distinct thyroid hormone profile characterized by a depressed free T3 (FT3) level and a preserved, normal, or elevated free T4 (FT4) level, resulting in an elevated FT4/FT3 ratio.
• Targeted correction: Clinical trials confirm that correcting a baseline selenium deficiency via supplementation successfully normalizes thyroid profiles by increasing circulating FT3 levels and lowering elevated FT4, thereby restoring a balanced conversion ratio.
• Context dependency: In selenium-replete, euthyroid adults, multiple randomized controlled trials have demonstrated that further selenium supplementation does not alter FT3, FT4, or thyroid hormone ratios, showing that this endocrine relationship is specific to states of systemic depletion.

Mechanistic explanations

• Selenocysteine active sites: Iodothyronine deiodinases (DIO1, DIO2, and DIO3) are obligate selenoproteins that contain a highly conserved selenocysteine (Sec) residue at their active catalytic centers. The selenium atom provides the necessary nucleophilicity and halogen-bonding capacity to facilitate rapid deiodination.
• T4-to-T3 activation: DIO1 and DIO2 catalyze outer-ring deiodination. The selenolate group of the active-site Sec residue forms a transient halogen bond with the iodine atom of T4, yielding an oxidized selenyl-iodide intermediate and releasing the biologically active T3 hormone.
• Peripheral vs. glandular preservation: Under selenium deficiency, the thyroid gland preferentially retains available selenium to maintain local deiodinase expression. Consequently, peripheral tissues (such as the liver and kidney, where DIO1 activity drives systemic T3 production) bear the brunt of systemic depletion. This tissue-specific triage leaves peripheral T4-to-T3 conversion impaired while maintaining normal thyroid-gland function and stable FT4 levels.

Bottom line

Selenium is chemically indispensable for the iodothyronine deiodinases that convert T4 to active T3. Systemic selenium deficiency impairs this conversion, leading to a clinical pattern of low free T3 with preserved free T4, which is correctable with selenium repletion in deficient individuals.